Susquehanna International Group’s Insmed INSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $28.4M | Sell |
173,630
-14,946
| -8% | -$2.3M | ﹤0.01% | 1796 |
|
|
2025
Q4 | $32.8M | Sell |
188,576
-44,530
| -19% | -$8.13M | ﹤0.01% | 1738 |
|
|
2025
Q3 | $33.6M | Buy |
233,106
+20,884
| +10% | +$2.56M | ﹤0.01% | 1683 |
|
|
2025
Q2 | $21.4M | Sell |
212,222
-236,392
| -53% | -$18.1M | ﹤0.01% | 1930 |
|
|
2025
Q1 | $34.2M | Buy |
448,614
+4,179
| +0.9% | +$320K | 0.01% | 1277 |
|
|
2024
Q4 | $30.7M | Buy |
444,435
+182,889
| +70% | +$13.2M | ﹤0.01% | 1511 |
|
|
2024
Q3 | $19.1M | Buy |
261,546
+110,522
| +73% | +$8.16M | ﹤0.01% | 1878 |
|
|
2024
Q2 | $10.1M | Buy |
151,024
+5,526
| +4% | +$214K | ﹤0.01% | 2465 |
|
|
2024
Q1 | $3.95M | Buy |
145,498
+29,052
| +25% | +$813K | ﹤0.01% | 4036 |
|
|
2023
Q4 | $3.61M | Sell |
116,446
-137,396
| -54% | -$3.56M | ﹤0.01% | 4277 |
|
|
2023
Q3 | $6.41M | Sell |
253,842
-2,463
| -1% | -$56.3K | ﹤0.01% | 3146 |
|
|
2023
Q2 | $5.41M | Sell |
256,305
-59,101
| -19% | -$1.12M | ﹤0.01% | 3388 |
|
|
2023
Q1 | $5.38M | Buy |
315,406
+278,240
| +749% | +$5.41M | ﹤0.01% | 3361 |
|
|
2022
Q4 | $743K | Sell |
37,166
-140,319
| -79% | -$2.71M | ﹤0.01% | 6867 |
|
|
2022
Q3 | $3.82M | Buy |
177,485
+121,356
| +216% | +$2.91M | ﹤0.01% | 3601 |
|
|
2022
Q2 | $1.11M | Sell |
56,129
-22,954
| -29% | -$481K | ﹤0.01% | 6277 |
|
|
2022
Q1 | $1.86M | Sell |
79,083
-6,172
| -7% | -$143K | ﹤0.01% | 5646 |
|
|
2021
Q4 | $2.32M | Buy |
85,255
+6,983
| +9% | +$200K | ﹤0.01% | 5158 |
|
|
2021
Q3 | $2.16M | Buy |
78,272
+32,397
| +71% | +$850K | ﹤0.01% | 5663 |
|
|
2021
Q2 | $1.31M | Buy |
45,875
+19,653
| +75% | +$583K | ﹤0.01% | 7020 |
|
|
2021
Q1 | $893K | Sell |
26,222
-6,167
| -19% | -$236K | ﹤0.01% | 8028 |
|
|
2020
Q4 | $1.08M | Sell |
32,389
-423
| -1% | -$15.5K | ﹤0.01% | 6550 |
|
|
2020
Q3 | $1.05M | Buy |
32,812
+1,569
| +5% | +$45.1K | ﹤0.01% | 5992 |
|
|
2020
Q2 | $861K | Sell |
31,243
-43,303
| -58% | -$1.03M | ﹤0.01% | 6238 |
|
|
2020
Q1 | $1.2M | Sell |
74,546
-50,473
| -40% | -$1.2M | ﹤0.01% | 4981 |
|
|
2019
Q4 | $2.98M | Sell |
125,019
-50,124
| -29% | -$1.02M | ﹤0.01% | 3707 |
|
|
2019
Q3 | $3.09M | Buy |
175,143
+54,109
| +45% | +$1.04M | ﹤0.01% | 3436 |
|
|
2019
Q2 | $3.1M | Buy |
+121,034
| New | +$3.37M | ﹤0.01% | 3397 |
|
|
2017
Q1 | – | Sell |
-115,572
| Closed | -$1.78M | – | 9419 |
|
|
2016
Q4 | $1.53M | Buy |
+115,572
| New | +$1.58M | ﹤0.01% | 4624 |
|
|
2016
Q3 | – | Sell |
-63,305
| Closed | -$792K | – | 8705 |
|
|
2016
Q2 | $624K | Buy |
63,305
+14,658
| +30% | +$171K | ﹤0.01% | 5754 |
|
|
2016
Q1 | $616K | Buy |
48,647
+38,231
| +367% | +$503K | ﹤0.01% | 6029 |
|
|
2015
Q4 | $189K | Sell |
10,416
-20,207
| -66% | -$356K | ﹤0.01% | 8475 |
|
|
2015
Q3 | $569K | Sell |
30,623
-444
| -1% | -$11.1K | ﹤0.01% | 6869 |
|
|
2015
Q2 | $759K | Buy |
+31,067
| New | +$705K | ﹤0.01% | 6775 |
|
|
2015
Q1 | – | Sell |
-51,563
| Closed | -$908K | – | 9640 |
|
|
2014
Q4 | $798K | Buy |
51,563
+38,641
| +299% | +$548K | ﹤0.01% | 6309 |
|
|
2014
Q3 | $169K | Sell |
12,922
-14,771
| -53% | -$223K | ﹤0.01% | 8812 |
|
|
2014
Q2 | $553K | Sell |
27,693
-152,747
| -85% | -$2.26M | ﹤0.01% | 7275 |
|
|
2014
Q1 | $3.44M | Buy |
180,440
+167,272
| +1,270% | +$3.18M | ﹤0.01% | 3429 |
|
|
2013
Q4 | $224K | Sell |
13,168
-146
| -1% | -$2.24K | ﹤0.01% | 8064 |
|
|
2013
Q3 | $208K | Buy |
+13,314
| New | +$169K | ﹤0.01% | 7720 |
|
Other funds holding INSM
DGM
VPM
VCM
BBA
Susquehanna International Group's INSM Position: Q1 2026 in Review
Susquehanna International Group reduced its Insmed (INSM) stake by 7.9% in Q1 2026, selling an estimated $2.3M and leaving 173,630 shares worth $28.4M. The position accounts for ﹤0.01% of the portfolio, ranked #1796.
Susquehanna International Group first reported a position in INSM in Q3 2013 and has held it in 40 quarters since. The position peaked at $34.2M in Q1 2025. 672 funds tracked by Wall St. Rank hold INSM as of Q1 2026.
- Susquehanna International Group held 173,630 shares of Insmed worth $28.4M as of Q1 2026.
- Susquehanna International Group sold 14,946 Insmed shares in Q1 2026, an estimated $2.3M.
- Insmed made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #1796 holding.
- Susquehanna International Group first reported a position in Insmed in Q3 2013 and has held it in 40 quarters since.
- Susquehanna International Group's Insmed position peaked at $34.2M in Q1 2025.
- 672 funds tracked by Wall St. Rank held Insmed as of Q1 2026.
Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.